180 Life Sciences's total liabilities is $39M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), ATNF shows a total liabilities of $39M. That compares with $3.9M in the prior-year period — up 895.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ATNF's total liabilities is now $39M (was $3.9M) — a 895.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 180 Life Sciences is outperforming or lagging.
Tracking ATNF's total liabilities over time shows whether 180 Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $39M That compares with $3.9M in the prior-year period — up 895.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has 180 Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $39M) with ownership activity and broader fundamentals.
180 Life Sciences's total liabilities is $39M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.